MedPath

A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

Active, not recruiting
Conditions
NHL
Registration Number
NCT04139252
Lead Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland
Brief Summary

Observational prospective study. Patients with DLBCL and HGBCL will be enrolled in the study to collect samples for developing a blood based assay allowing biomarker driven treatment in the future.

Detailed Description

The rationale of this study is that, due to the lack of successful salvage options, first-line treatment outcome needs to be improved. To make this possible, a crucial condition is optimal identification of patients that will not be cured on R-CHOP. The aim of this protocol is to develop new tools to monitor treatment response and disease outcome. Molecular monitoring of treatment response through liquid biopsies (LB) is such a promising new tool.

The primary objective is to collect liquid biopsy samples of patients with newly diagnosed DLBCL/HGBCL to develop a blood based assay allowing biomarker driven treatment in the future.

The secondary objectives are to collect clinical data and pre-treatment tissue samples (for determining molecular profiles) to allow for correlation to the blood based assay.

This study is designed for patients with newly diagnosed DLBCL and HGBCL ≥ 18 yr.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Patients diagnosed with newly diagnosed DLBCL (including HGBCL- NOS and HGBCL-DH) according to WHO classification 2016
  • Ann Arbor stage II-IV
  • Patients intended to be treated with 6 cycles R-CHOP (or DA-EPOCH-R) as first-line treatment (successive inclusion in HOVON 151 or HOVON 152 is possible)
  • Age ≥ 18 years
Exclusion Criteria
  • Patients with limited stage I, II disease planned to receive 3 cycles of R-CHOP + radiotherapy, or 4 x R-CHOP+ 2R

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tissue material24 months

For genomic analysis and clinical outcome data

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (60)

NL-Almelo-ZGTALMELO

🇳🇱

Almelo, Netherlands

NL-Deventer-DZ

🇳🇱

Deventer, Netherlands

NL-Almere-FLEVOZIEKENHUIS

🇳🇱

Almere, Netherlands

NL-Amstelveen-AMSTELLAND

🇳🇱

Amstelveen, Netherlands

NL-Den Bosch-JBZ

🇳🇱

Den Bosch, Netherlands

NL-Den Haag-HMCWESTEINDE

🇳🇱

Den Haag, Netherlands

NL-Dordrecht-ASZ

🇳🇱

Dordrecht, Netherlands

NL-Dirksland-VANWEELBETHESDA

🇳🇱

Dirksland, Netherlands

NL-Ede-ZGV

🇳🇱

Ede, Netherlands

NL-Emmen-SCHEPER

🇳🇱

Emmen, Netherlands

NL-Enschede-MST

🇳🇱

Enschede, Netherlands

NL-Geldrop-STANNA

🇳🇱

Geldrop, Netherlands

NL-Heerenveen-TJONGERSCHANS

🇳🇱

Heerenveen, Netherlands

NL-Hoofddorp-SPAARNEGASTHUIS

🇳🇱

Hoofddorp, Netherlands

NL-Hoorn-DIJKLANDERHOORN

🇳🇱

Hoorn, Netherlands

NL-Leeuwarden-MCL

🇳🇱

Leeuwarden, Netherlands

NL-Tilburg-ETZ

🇳🇱

Tilburg, Netherlands

NL-Zutphen-GELREZUTPHEN

🇳🇱

Zutphen, Netherlands

NL-Gorinchem-BEATRIX

🇳🇱

Gorinchem, Netherlands

NL-Leiden-LUMC

🇳🇱

Leiden, Netherlands

NL-Nijmegen-CWZ

🇳🇱

Nijmegen, Netherlands

NL-Rotterdam-SFG

🇳🇱

Rotterdam, Netherlands

NL-Sneek-ANTONIUSSNEEK

🇳🇱

Sneek, Netherlands

NL-Utrecht-UMCUTRECHT

🇳🇱

Utrecht, Netherlands

NL-Venlo-VIECURI

🇳🇱

Venlo, Netherlands

NL-Winterswijk-SKBWINTERSWIJK

🇳🇱

Winterswijk, Netherlands

NL-Alkmaar-NWZ

🇳🇱

Alkmaar, Netherlands

NL-Amersfoort-MEANDERMC

🇳🇱

Amersfoort, Netherlands

NL-Amsterdam-AMC

🇳🇱

Amsterdam, Netherlands

NL-Amsterdam-OLVG

🇳🇱

Amsterdam, Netherlands

NL-Arnhem-RIJNSTATE

🇳🇱

Arnhem, Netherlands

NL-Assen-WZA

🇳🇱

Assen, Netherlands

NL-Beverwijk-RKZ

🇳🇱

Beverwijk, Netherlands

NL-Capelle a/d IJssel-YSL

🇳🇱

Capelle Aan Den IJssel, Netherlands

NL-Doetinchem-SLINGELAND

🇳🇱

Doetinchem, Netherlands

NL-Goes-ADRZ

🇳🇱

Goes, Netherlands

NL-Delft-RDGG

🇳🇱

Delft, Netherlands

NL-Den Haag-HAGA

🇳🇱

Den Haag, Netherlands

NL-Eindhoven-MAXIMAMC

🇳🇱

Eindhoven, Netherlands

NL-Harderwijk-STJANSDALHARDERWIJK

🇳🇱

Harderwijk, Netherlands

NL-Groningen-UMCG

🇳🇱

Groningen, Netherlands

NL-Hardenberg-SAXENBURGH

🇳🇱

Hardenberg, Netherlands

NL-Helmond-ELKERLIEK

🇳🇱

Helmond, Netherlands

NL-Maastricht-MUMC

🇳🇱

Maastricht, Netherlands

NL-Nieuwegein-ANTONIUS

🇳🇱

Nieuwegein, Netherlands

NL-Roermond-LZR

🇳🇱

Roermond, Netherlands

NL-Rotterdam-MAASSTADZIEKENHUIS

🇳🇱

Rotterdam, Netherlands

NL-Roosendaal-BRAVIS

🇳🇱

Roosendaal, Netherlands

NL-Rotterdam-IKAZIA

🇳🇱

Rotterdam, Netherlands

NL-Uden-BERNHOVEN

🇳🇱

Uden, Netherlands

NL-Tiel-RIVIERENLAND

🇳🇱

Tiel, Netherlands

NL-Utrecht-DIAKONESSENUTRECHT

🇳🇱

Utrecht, Netherlands

NL-Zwolle-ISALA

🇳🇱

Zwolle, Netherlands

NL-Amsterdam-VUMC

🇳🇱

Amsterdam, Netherlands

NL-Breda-AMPHIA

🇳🇱

Breda, Netherlands

NL-Eindhoven-CATHARINA

🇳🇱

Eindhoven, Netherlands

NL-Gouda-GROENEHART

🇳🇱

Gouda, Netherlands

NL-Rotterdam-ERASMUSMC

🇳🇱

Rotterdam, Netherlands

NL-Spijkenisse-SPIJKENISSEMC

🇳🇱

Spijkenisse, Netherlands

NL-Terneuzen-ZORGSAAM

🇳🇱

Terneuzen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath